Image courtesy of Oath Surgical via LinkedInOath Surgical has secured $24 million in series A funding to expand into new specialties, grow its nationwide value-based network of surgeon-owned, tech-driven surgery centers, and develop OathOS, an AI platform aimed at replacing the industry’s patchwork of systems.
Funding for the Portland, Oregon-based company was led by FPV Ventures with participation from McKessen Ventures and existing investors OSE, Black Opal Ventures, Tau Ventures and Rogue VC. The new infusion of capital brings total funding to $35 million.
“Oath is planning a rapid expansion of its tech-forward, value-oriented outpatient surgical centers across the country,” Dr. Oliver Keown, Oath Surgical founder and CEO, told ASC News.
In the U.S., hospital spending – including inpatient and outpatient surgical procedures – is the largest single category of national health expenditures, according to KFF. While total costs vary, surgery is generally considered the primary cost driver.
By 2026, Medicare is expected to allow over 51 million procedures to shift to outpatient settings, creating demand for high-tech centers capable of delivering complex care safely and at scale.
“Surgery is at a turning point,” Keown said in a statement. “The shift of complex care out of hospitals is inevitable, but it won’t happen by chance. It will take a new kind of system — high-tech, surgeon-led, and aligned across patients, providers and payors. That’s what we’re building at Oath.”
OathOS automates the surgical process by offering an AI-powered operating room, streamlining workflows and providing real-time data. Patients benefit from more efficient care and a smoother experience. Payers gain from consistency, lower costs and transparent outcomes, according to the company.
Within its first year, Oath Surgical acquired two ambulatory surgery centers, initiated development of a third de novo center and expanded its national network of over 150 surgeon partners.
Additionally, the company has reported up to 80% cost savings compared to hospital-based procedures, a 98.5% patient satisfaction score, a complication rate of less than 0.25% across complex surgeries and same-day discharge with patients recovering in a matter of days.
With this funding, Oath aims for nationwide growth. The company intends to expand its network of high-tech, multispecialty centers into new markets, offering programs in urology, gynecology, general surgery, neurology, spine, ear, nose and throat, orthopedics, pain management and surgical oncology.
